Switch to:
Also traded in: Canada, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.29
HLTH's Cash-to-Debt is ranked higher than
51% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. HLTH: 0.29 )
Ranked among companies with meaningful Cash-to-Debt only.
HLTH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08  Med: 2.49 Max: No Debt
Current: 0.29
Equity-to-Asset 0.47
HLTH's Equity-to-Asset is ranked higher than
55% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HLTH: 0.47 )
Ranked among companies with meaningful Equity-to-Asset only.
HLTH' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.27  Med: 0.42 Max: 0.74
Current: 0.47
-0.27
0.74
Interest Coverage 2.51
HLTH's Interest Coverage is ranked lower than
82% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 7.25 vs. HLTH: 2.51 )
Ranked among companies with meaningful Interest Coverage only.
HLTH' s Interest Coverage Range Over the Past 10 Years
Min: 2.51  Med: N/A Max: No Debt
Current: 2.51
Piotroski F-Score: 3
Altman Z-Score: 1.59
Beneish M-Score: -2.32
WACC vs ROIC
0.13%
3.20%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 3.51
HLTH's Operating Margin % is ranked lower than
67% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. HLTH: 3.51 )
Ranked among companies with meaningful Operating Margin % only.
HLTH' s Operating Margin % Range Over the Past 10 Years
Min: -13.69  Med: 14.3 Max: 64.77
Current: 3.51
-13.69
64.77
Net Margin % 2.26
HLTH's Net Margin % is ranked lower than
62% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. HLTH: 2.26 )
Ranked among companies with meaningful Net Margin % only.
HLTH' s Net Margin % Range Over the Past 10 Years
Min: -243.59  Med: 2.85 Max: 22.18
Current: 2.26
-243.59
22.18
ROE % 4.92
HLTH's ROE % is ranked lower than
66% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. HLTH: 4.92 )
Ranked among companies with meaningful ROE % only.
HLTH' s ROE % Range Over the Past 10 Years
Min: -141.14  Med: -3.11 Max: 61.25
Current: 4.92
-141.14
61.25
ROA % 2.58
HLTH's ROA % is ranked lower than
57% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. HLTH: 2.58 )
Ranked among companies with meaningful ROA % only.
HLTH' s ROA % Range Over the Past 10 Years
Min: -96.85  Med: 2.79 Max: 29.27
Current: 2.58
-96.85
29.27
ROC (Joel Greenblatt) % 17.24
HLTH's ROC (Joel Greenblatt) % is ranked higher than
52% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. HLTH: 17.24 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HLTH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -61.1  Med: 73.21 Max: 269.5
Current: 17.24
-61.1
269.5
3-Year Revenue Growth Rate 63.90
HLTH's 3-Year Revenue Growth Rate is ranked higher than
99% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. HLTH: 63.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HLTH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -48.5  Med: -6.95 Max: 205.5
Current: 63.9
-48.5
205.5
3-Year EBITDA Growth Rate 13.40
HLTH's 3-Year EBITDA Growth Rate is ranked higher than
65% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. HLTH: 13.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HLTH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -53.8  Med: 10.3 Max: 126.2
Current: 13.4
-53.8
126.2
3-Year EPS without NRI Growth Rate 26.00
HLTH's 3-Year EPS without NRI Growth Rate is ranked higher than
80% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. HLTH: 26.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HLTH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -78.9  Med: 26 Max: 223.8
Current: 26
-78.9
223.8
GuruFocus has detected 5 Warning Signs with Nobilis Health Corp $HLTH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HLTH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

HLTH Guru Trades in Q1 2016

Jim Simons 157,500 sh (+64.75%)
Chuck Royce 1,235,700 sh (+28.62%)
» More
Q2 2016

HLTH Guru Trades in Q2 2016

Chuck Royce 1,590,800 sh (+28.74%)
Jim Simons Sold Out
» More
Q3 2016

HLTH Guru Trades in Q3 2016

Jim Simons 33,500 sh (New)
Chuck Royce 1,515,800 sh (-4.71%)
» More
Q4 2016

HLTH Guru Trades in Q4 2016

Jim Simons Sold Out
Chuck Royce 1,465,800 sh (-3.30%)
» More
» Details

Insider Trades

Latest Guru Trades with HLTH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621999    SIC: 8619
Compare:OTCPK:MIHI, OTCPK:CATS, NYSE:AAC, NYSE:CCM, OTCPK:AMEH, NAS:JYNT, NYSE:QHC, OTCPK:FCHS, NYSE:ADPT, OTCPK:CCEL, NAS:BIOS, OTCPK:BNKL, AMEX:AMS, OTCPK:CVHIF, OTCPK:BICX, OTCPK:JRSS, AMEX:SSY, OTCPK:WNDM, AMEX:HH, OTCPK:PFHO » details
Traded in other countries:NHC.Canada, NH1.Germany,
Nobilis Health Corp is a healthcare development and management company. It is engaged in development and management of ambulatory surgical centers providing medical care & healthcare delivery services.

Northstar Healthcare, Inc. partners with the physicians in the development and management of ambulatory surgery centres in the United States. It manages an ambulatory surgery centre in Dallas and two pain management clinics in Houston.

Ratios

vs
industry
vs
history
PE Ratio 24.29
HLTH's PE Ratio is ranked higher than
97% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. HLTH: 24.29 )
Ranked among companies with meaningful PE Ratio only.
HLTH' s PE Ratio Range Over the Past 10 Years
Min: 2.83  Med: 19.89 Max: 723
Current: 24.29
2.83
723
PE Ratio without NRI 24.29
HLTH's PE Ratio without NRI is ranked higher than
97% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. HLTH: 24.29 )
Ranked among companies with meaningful PE Ratio without NRI only.
HLTH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 2.83  Med: 19.89 Max: 723
Current: 24.29
2.83
723
PB Ratio 0.92
HLTH's PB Ratio is ranked higher than
88% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. HLTH: 0.92 )
Ranked among companies with meaningful PB Ratio only.
HLTH' s PB Ratio Range Over the Past 10 Years
Min: 0.64  Med: 2.84 Max: 12.83
Current: 0.92
0.64
12.83
PS Ratio 0.46
HLTH's PS Ratio is ranked higher than
84% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. HLTH: 0.46 )
Ranked among companies with meaningful PS Ratio only.
HLTH' s PS Ratio Range Over the Past 10 Years
Min: 0.19  Med: 0.83 Max: 3.57
Current: 0.46
0.19
3.57
Price-to-Operating-Cash-Flow 73.92
HLTH's Price-to-Operating-Cash-Flow is ranked lower than
97% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 13.47 vs. HLTH: 73.92 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HLTH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.45  Med: 16.9 Max: 125
Current: 73.92
0.45
125
EV-to-EBIT 12.25
HLTH's EV-to-EBIT is ranked higher than
77% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. HLTH: 12.25 )
Ranked among companies with meaningful EV-to-EBIT only.
HLTH' s EV-to-EBIT Range Over the Past 10 Years
Min: -9.9  Med: 5.35 Max: 30.1
Current: 12.25
-9.9
30.1
EV-to-EBITDA 7.82
HLTH's EV-to-EBITDA is ranked higher than
78% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 14.29 vs. HLTH: 7.82 )
Ranked among companies with meaningful EV-to-EBITDA only.
HLTH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -28.5  Med: 4.9 Max: 378.2
Current: 7.82
-28.5
378.2
Current Ratio 2.48
HLTH's Current Ratio is ranked higher than
85% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. HLTH: 2.48 )
Ranked among companies with meaningful Current Ratio only.
HLTH' s Current Ratio Range Over the Past 10 Years
Min: 0.78  Med: 2.37 Max: 4.51
Current: 2.48
0.78
4.51
Quick Ratio 2.41
HLTH's Quick Ratio is ranked higher than
86% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.16 vs. HLTH: 2.41 )
Ranked among companies with meaningful Quick Ratio only.
HLTH' s Quick Ratio Range Over the Past 10 Years
Min: 0.66  Med: 2.13 Max: 4.26
Current: 2.41
0.66
4.26
Days Inventory 1.00
HLTH's Days Inventory is ranked higher than
94% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 18.84 vs. HLTH: 1.00 )
Ranked among companies with meaningful Days Inventory only.
HLTH' s Days Inventory Range Over the Past 10 Years
Min: 1  Med: 42.57 Max: 1996.6
Current: 1
1
1996.6
Days Sales Outstanding 159.61
HLTH's Days Sales Outstanding is ranked lower than
95% of the 174 Companies
in the Global Medical Care industry.

( Industry Median: 44.22 vs. HLTH: 159.61 )
Ranked among companies with meaningful Days Sales Outstanding only.
HLTH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.52  Med: 84.27 Max: 175.75
Current: 159.61
44.52
175.75
Days Payable 6.00
HLTH's Days Payable is ranked lower than
95% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. HLTH: 6.00 )
Ranked among companies with meaningful Days Payable only.
HLTH' s Days Payable Range Over the Past 10 Years
Min: 6  Med: 53.75 Max: 19118.01
Current: 6
6
19118.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -28.30
HLTH's 3-Year Average Share Buyback Ratio is ranked lower than
87% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. HLTH: -28.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HLTH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -37.4  Med: -26 Max: 27.4
Current: -28.3
-37.4
27.4

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 85.00
HLTH's Price-to-Net-Current-Asset-Value is ranked lower than
99.99% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. HLTH: 85.00 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
HLTH' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.67  Med: 20.34 Max: 105
Current: 85
3.67
105
Price-to-Tangible-Book 2.15
HLTH's Price-to-Tangible-Book is ranked higher than
67% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 3.25 vs. HLTH: 2.15 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
HLTH' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.69  Med: 3.69 Max: 46.67
Current: 2.15
1.69
46.67
Price-to-Intrinsic-Value-Projected-FCF 1.01
HLTH's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
99.99% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. HLTH: 1.01 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HLTH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.05  Med: 0.36 Max: 2.7
Current: 1.01
0.05
2.7
Price-to-Median-PS-Value 0.55
HLTH's Price-to-Median-PS-Value is ranked lower than
99.99% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. HLTH: 0.55 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HLTH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.23  Med: 0.67 Max: 1.97
Current: 0.55
0.23
1.97
Price-to-Graham-Number 1.52
HLTH's Price-to-Graham-Number is ranked lower than
99.99% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 2.23 vs. HLTH: 1.52 )
Ranked among companies with meaningful Price-to-Graham-Number only.
HLTH' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.52  Med: 1.28 Max: 2.44
Current: 1.52
0.52
2.44
Earnings Yield (Greenblatt) % 8.16
HLTH's Earnings Yield (Greenblatt) % is ranked higher than
81% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.94 vs. HLTH: 8.16 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HLTH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.3  Med: 17 Max: 103.9
Current: 8.16
3.3
103.9

More Statistics

Revenue (TTM) (Mil) $285.7
EPS (TTM) $ 0.07
Beta-0.77
Short Percentage of Float11.39%
52-Week Range $1.25 - 4.66
Shares Outstanding (Mil)77.81

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 332 334 316
EPS ($) 0.37 0.37 0.39
EPS without NRI ($) 0.37 0.37 0.39
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for HLTH

Headlines

Articles On GuruFocus.com

More From Other Websites
Nobilis Health Corp. :HLTH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017 Mar 23 2017
Nobilis Health Corp. Appoints New Executive Vice President of Operations Mar 20 2017
Nobilis Health Corp. Appoints New Executive Vice President of Operations Mar 20 2017
NOBILIS HEALTH CORP. Financials Mar 18 2017
NOBILIS HEALTH CORP. Files SEC form 8-K, Financial Statements and Exhibits Mar 17 2017
Nobilis to Present at Oppenheimer Healthcare Conference Mar 15 2017
Nobilis to Present at Oppenheimer Healthcare Conference Mar 15 2017
Post Earnings Coverage as Tenet's Q4 Results Missed Market Expectations Mar 15 2017
NOBILIS HEALTH CORP. Files SEC form 10-K, Annual Report Mar 14 2017
Nobilis Health Announces Completion of Acquisition of Hamilton Vein Center Mar 13 2017
Nobilis Health Announces Completion of Acquisition of Hamilton Vein Center Mar 13 2017
Nobilis Health posts 4Q profit Mar 13 2017
Nobilis Health posts 4Q profit Mar 13 2017
Nobilis Health Reports Fourth Quarter 2016 Financial Results Mar 13 2017
Nobilis Health Reports Fourth Quarter 2016 Financial Results Mar 13 2017
Nobilis Health Corp. Announces Fourth Quarter and Full Year 2016 Earnings Release Date and... Mar 08 2017
Nobilis Health Corp. Announces Fourth Quarter and Full Year 2016 Earnings Release Date and... Mar 08 2017
NOBILIS HEALTH CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Mar 08 2017
Houston health care companies name new CFOs Feb 15 2017
NOBILIS HEALTH CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Feb 13 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)